Sri Lanka vs Venezuela, Bolivarian Republic of: Treatment success rate for patients treated for MDR-TB
Sri Lanka
79.0%
in 2022
Venezuela, Bolivarian Republic of
78.0%
in 2022
Sri Lanka rank
56th
Venezuela, Bolivarian Republic of rank
59th
Treatment success rate for patients treated for MDR-TB over time
- Sri Lanka
- Venezuela, Bolivarian Republic of
How they compare
Sri Lanka currently reports 79.0% against 78.0% in Venezuela, Bolivarian Republic of, a difference of 1.0%.
The two have swapped places 7 times across 17 shared years of data; in 2006 it was Venezuela, Bolivarian Republic of ahead.
Sri Lanka ranks 56th and Venezuela, Bolivarian Republic of ranks 59th of 163 countries.
Across the 3 decades both report, Sri Lanka averaged higher in 1 and Venezuela, Bolivarian Republic of in 2.
Head to head by decade
| Decade | Sri Lanka | Venezuela, Bolivarian Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 31.5% | 64.2% | 32.8% | Venezuela, Bolivarian Republic of |
| 2010s | 75.6% | 62.4% | 13.2% | Sri Lanka |
| 2020s | 56.0% | 70.0% | 14.0% | Venezuela, Bolivarian Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Sri Lanka or Venezuela, Bolivarian Republic of?
- Sri Lanka, at 79.0% against 78.0% in Venezuela, Bolivarian Republic of as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Sri Lanka and Venezuela, Bolivarian Republic of?
- 1.0%, with Sri Lanka ahead.
- How many years of comparable data are there for Sri Lanka and Venezuela, Bolivarian Republic of?
- 17 years are reported by both, from 2006 to 2022.
- How do Sri Lanka and Venezuela, Bolivarian Republic of rank globally for treatment success rate for patients treated for mdr-tb?
- Sri Lanka ranks 56th and Venezuela, Bolivarian Republic of ranks 59th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.